Peptide 2.0Sourced with proof
Back to all compounds

Retatrutide

Triple GLP-1 / GIP / glucagon receptor agonist

A triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. It is studied for substantial weight reduction and broad metabolic effects, with the glucagon arm of interest for energy expenditure research.

Commonly explored for
Fat lossRecompositionCardiovascularHormonal balance

Verified sellers

3 sellers

Educational information only. Peptide 2.0 is an information and marketplace platform, not a pharmacy, and does not make medical claims. Orders are placed with and fulfilled by the seller, not by Peptide 2.0.